Dr. Hapani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
13301 N Meridian Ave
Suite 501
Oklahoma City, OK 73120Phone+1 405-752-0871Fax+1 405-755-9510
Education & Training
Stony Brook Medicine/University HospitalFellowship, Hematology and Medical Oncology, 2009 - 2013- Stony Brook Medicine/University HospitalResidency, Internal Medicine, 2007 - 2010
B.J. Medical College - University of PuneClass of 2005
Certifications & Licensure
OK State Medical License 2013 - 2025
MI State Medical License 2010 - 2023- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 36 citationsRisk of liver toxicity with the angiogenesis inhibitor pazopanib in cancer patients.Samir Kapadia, Sanjaykumar Hapani, Toni K. Choueiri, Shenhong Wu
Acta Oncologica. 2013-07-11 - 5 citationsImages in clinical medicine. Enlarged spleen with a heterogeneous pattern.Rosa Nouvini, Sanjaykumar Hapani
The New England Journal of Medicine. 2013-06-26 - Test Results Follow-Up: A Systematic ReviewShai Gavi, Vishal Ranpura, Sanjaykumar Hapani, Abdo Kataya, Bala Prakash
Journal of General Internal Medicine. 2013-02-01
Press Mentions
FDA Approves Drug to Help People Diagnosed with Rare Blood DiseaseNovember 21st, 2019- People Learn They Have Rare Blood Disease After Seeing Man's Story on KOCO 5November 13th, 2019
- Paralysis, Pain, Hallucinations: Oklahoma Man’s Rare Disease DiagnosedMay 10th, 2019
- Join now to see all
Professional Memberships
- Member
Other Languages
- Gujarati, Hindi, Urdu
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
